FDA's Sharfstein bemoans speed of regulatory initiatives; India wants cold chain culture;

> "I keep a list of things that I wish were moving faster and a list of things moving at just the right speed, and there's nothing on the second list."--FDA Deputy Commissioner Joshua Sharfstein. Article

> India's Pharmaceuticals Export Promotion Council will study warehousing conditions at sea ports, an early step in its effort to create a cold chain culture. Report

> Start-up BioLOGIS aims to be a one-stop vendor for cargo security, shipment tracking and biometric condition monitoring. Story

> Pfizer is spending $42 million to build a facility at its biotech packaging and distribution site in Havant, UK. Article

> Almac's tech business unit has joined the analytical testing and clinical supplies units in occupying the company's just-completed North American headquarters in Souderton, PA. Almac release

> Becton, Dickinson and Co. has opened the GMP-compliant biosciences advanced bioprocessing production facility in Miami. News

> Pharmetics is pulling up stakes in Niagra, imperiling 200 manufacturing jobs. Article

> Nigerian drugmakers were skipped over for the proposed Affordable Medicine for Malaria project because none were considered competent. Story

> Biovet, a subsidiary of Huvepharma, is building a biopharma plant in Razgrad, Bulgaria. Item

> Bormioli Rocco Glass has unveiled the Delta lightweight glass vials for injectables, intended to replace tubular glass vials. Bormioli release

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.